
The Pharmaceutical Research and Manufacturers of America (PhRMA) outlined initiatives to bolster U.S. manufacturing, ease patient costs, and improve access to medicine.
The trade group emphasized that these efforts reflect the biopharmaceutical industry’s long-term commitment to American patients and workers.